Abstract

Preview
For almost fifty years, improvements in donor selection and screening have led to a continuous reduction in the risk of transfusion-transmitted hepatitis B virus (HBV). However, transmission can still occur when blood is collected from hepatitis B surface antigen (HBsAg) negative donors during the pre-seroconversion window period. Another source of transmission is represented by donors with occult HBV infection (OBI), a condition characterised by persistent HBV carriage in the absence of detectable HBsAg. In many countries, this prompted the introduction of nucleic acid testing (NAT) for HBV and/or antibodies to hepatitis B core (anti-HBc) testing in order to improve detection of infectious donations. [ ... ]

Downloads

Authors

Daniele Prati - Department of Transfusion Medicine and Haematology, "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico", Milan

Luca Valenti - Department of Transfusion Medicine and Haematology, "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico", Milan; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

  • Abstract viewed - 8 times
  • PDF downloaded - 1 times